1. Home
  2. VTS vs CSTL Comparison

VTS vs CSTL Comparison

Compare VTS & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vitesse Energy Inc.

VTS

Vitesse Energy Inc.

N/A

Current Price

$14.86

Market Cap

733.0M

Sector

Energy

ML Signal

N/A

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

N/A

Current Price

$34.01

Market Cap

722.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VTS
CSTL
Founded
2014
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical Specialities
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
733.0M
722.8M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
VTS
CSTL
Price
$14.86
$34.01
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$21.50
★ $47.40
AVG Volume (30 Days)
★ 461.4K
370.4K
Earning Date
11-02-2026
11-05-2026
Dividend Yield
★ 11.78%
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
$273,989,000.00
★ $344,229,000.00
Revenue This Year
$25.89
$12.74
Revenue Next Year
N/A
$11.78
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 13.22
3.66
52 Week Low
$14.41
$17.72
52 Week High
$22.91
$44.28

Technical Indicators

Market Signals
Indicator
VTS
CSTL
Relative Strength Index (RSI) 26.55 48.60
Support Level N/A $33.90
Resistance Level $18.65 $34.23
Average True Range (ATR) 0.55 1.91
MACD -0.38 -0.16
Stochastic Oscillator 11.14 31.60

Price Performance

Historical Comparison
VTS
CSTL

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana with limited operations. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: